![]() |
市场调查报告书
商品编码
1372037
2030 年生物机械市场预测:按类型、电机类型、用途和地区分類的全球分析Biological Machines Market Forecasts to 2030 - Global Analysis By Type (Myosin, Dynein, Kinesin, Ribosomes and Other Types), Motor Type, Application and By Geography |
根据Stratistics MRC的数据,2023年全球生物机械市场规模为46亿美元,预计在预测期内将以38.4%的年复合成长率成长,到2030年达到453亿美元。
生物机器,也称为生物机器,是一种复杂的系统和小工具,其设计灵感来自于生物元素,例如细胞、蛋白质和遗传物质。他们的目的是执行特定的工作或职能。这些设备通常旨在复製或利用生物体的能力,用于各种工业、科学和医疗用途。这些设备有能力改变许多领域并提高我们的生物学和技术知识。
创造出能够与现有生物功能顺利工作的生物设备是可能的。它利用有机生物过程的精确性和有效性。透过专注于人体内的特定细胞和组织,它们可用于更精确地给药或更精确地执行业务。结合生物和合成成分可以创建具有改进或新功能的混合设备。这些可以是比全合成替代更有效的生物感测器、生物致动器和生物燃料电池。这些都是市场拓展的动力。
生物系统本质上是复杂且多变的。生物机器的行为很难预测和控制,因为它取决于多种变量,包括遗传、环境和细胞反应。此外,生物结构要素会随着时间的劣化,并且寿命有限。与传统机械系统相比,这限制了生物机器的长期效用和可靠性,从而限制了其市场扩张。
与传统的工业方法相比,生物系统通常产生较少的废弃物和危险产品,并且更环保。这些生物机器通常使用细菌、酵母和藻类等活生物体来生产各种产品,包括药品、生物燃料和化学物质。它们能够非常有效地将原材料转化为所需的产品,因此产生的废弃物更少。这可能会降低废弃物成本并实现更清洁的生产方法。这些都是影响市场拓展的因素。
生物机器在遏制和安全方面是危险的。基因改造生物可能会被意外释放,并可能对生态系统产生意想不到的影响。此外,这些设备可能不会总是像预期的那样节能。生物系统在细胞层面本质上是节能的,但当整合到机器中时,维护和管理这些组件所需的能量可能会很大。这些都是阻碍市场进一步扩大的因素。
自从新冠肺炎 (COVID-19) 疫情以来,物流业制定了严格的规定,贸易路线也被切断。产品从一地到另一地的运输受到供应链和物流部门法规的阻碍。然而,由于疫情期间的旅行禁令和边境关闭消除了进口,当地蜂蜜酒销量增加。此外,由于酒吧和餐厅长时间关闭,顾客被迫改变饮酒习惯。罐装葡萄酒等流行饮料预计将延续这一趋势。
在预测期内,肌球蛋白部分预计将是最大的。一种称为肌球蛋白的蛋白质对于许多生物功能至关重要,包括肌肉收缩。用于描述肌球蛋白驱动的分子马达的术语「生物机器」具有多种优点。它透过利用化学能 (ATP) 来产生机械力和运动,充当分子引擎。当我们沿着肌动蛋白丝「行走」时,它们会相互靠近,引起肌肉收缩和许多其他细胞功能。
机器学习领域预计在预测期内年复合成长率最高。混合系统通常称为生物机器,在使用机器学习时具有各种优势。这些系统将感测器和控制设备等人工元件与细胞和生物体等生物元件混合在一起,以提供灵活且适应性强的系统。由于演算法能够适应不断变化的环境条件和需求,这些系统可以动态地回应各种刺激。
预计北美在预测期内将占据最大的市场占有率。该地区是多家生物技术公司的所在地,这些公司致力于製造用于各种用途的生物机器,包括基因工程、细胞治疗和药物研发。该地区的大学和研究机构在生物机械相关领域进行前沿研究。为了发展这一领域,他们经常与商业伙伴和政府机构合作。
在预测期内,亚太地区的年复合成长率最高。该地区国家的合成生物学研究十分活跃。该领域为各种用途设计和建造生物系统、设备和零件,包括生物燃料生产、製药和环境清理。医疗用生物设备的开发是一项全球性的配合措施。这包括组织工程、人造器官的生产以及医疗设备生物活性材料的生产。
According to Stratistics MRC, the Global Biological Machines Market is accounted for $4.6 billion in 2023 and is expected to reach $45.3 billion by 2030 growing at a CAGR of 38.4% during the forecast period. Biological machines, also known bio-machines, are sophisticated systems or gadgets that get their design inspiration from or are made of biological elements like cells, proteins, or genetic material. They are intended to carry out certain jobs or functions. These devices are often designed to replicate or use the capacities of living things for a variety of uses, including as industrial, scientific, and medical ones. These devices have the power to transform a number of sectors and advance our knowledge of biology and technology.
It is possible to create biological devices that smoothly work with current biological functions. They utilize the accuracy and effectiveness of organic biological processes. They are used to administer medications or carry out duties more precisely by focusing on certain cells or tissues in the human body. Biological and synthetic components can be combined to create hybrid devices with improved or novel functionality. These could be more effective biosensors, bio actuators, or biofuel cells than completely synthetic substitutes. These are the elements driving the market's expansion.
Biological systems are naturally complicated and changeable. The behavior of biological machines can be difficult to anticipate and control since it depends on a wide range of variables, such as genetics, environment, and cellular reactions. Furthermore, biological components might deteriorate over time and have a finite lifetime. This restricts biological machines' long-term usefulness and dependability in comparison to conventional mechanical systems, which is limiting market expansion.
When compared to conventional industrial methods, biological systems often generate less waste and hazardous byproducts, making them more ecologically friendly. In order to create a variety of goods, including medicines, biofuels, chemicals, and more, these biological machines frequently employ living organisms like bacteria, yeast, or algae. They generate less waste since they are very effective at turning raw materials into the intended product. This may result in lower waste disposal costs and cleaner production methods. This is the element impacting the market's expansion.
Biological machinery is dangerous in terms of containment and safety. There is a chance that genetically modified organisms will be accidentally released, which might have unforeseen ecological effects. Additionally, it's possible that these devices aren't always as energy-efficient as intended. Although biological systems are naturally energy-efficient at the cellular level, the energy needs for maintaining and managing these components when they are incorporated into machines can be substantial. These are the elements preventing further market expansion.
Following COVID-19, strict rules were put in place for logistics, and trade channels were shut down. Transporting products from one location to another was hampered by regulations on the supply chain and logistics sector. Sales of local mead, however, increased as a result of the absence of imported goods brought on by travel bans and border closures during the epidemic. Additionally, because pubs and restaurants were closed for extended periods of time, customers were compelled to change their drinking habits. This trend is anticipated to continue because popular drinks like canned wine.
The myosin segment is expected to be the largest during the forecast period. A protein called myosin is essential for many biological functions, including muscle contraction. The term "biological machines" used to describe the myosin-driven molecular motors has multiple benefits. By utilizing chemical energy (ATP) to produce mechanical power and movement, it functions as a molecular motor. Actin filaments move past one another as it "walks" along them, triggering muscle contraction and a number of other cellular functions.
The machine learning segment is expected to have the highest CAGR during the forecast period. Biohybrid systems, commonly referred to as biological machines, provide various benefits when using machine learning. These systems mix artificial elements like sensors or controls with biological elements like cells or organisms to provide flexible and adaptable systems. These systems react dynamically to a variety of stimuli thanks to these algorithms' ability to adapt to changing environmental circumstances or needs.
North America is projected to hold the largest market share during the forecast period. There are several biotechnology businesses in this region that strive to create biological machines for a range of uses, including genetic engineering, cell therapy, and drug discovery. The region's universities and research facilities carry out cutting-edge studies in fields relating to biological machines. To progress the field, they frequently work together with business partners and governmental organizations.
Asia Pacific is projected to hold the highest CAGR over the forecast period. Synthetic biology research has been active throughout the region's nations. In this discipline, biological systems, devices, and components are designed and built for a variety of uses, including the generation of biofuel, medicines, and environmental cleanup. The creation of biological devices for use in medicine is a worldwide endeavor. This covers tissue engineering, the production of artificial organs, and the creation of bioactive materials for medical equipment.
Some of the key players in Biological Machines market include: Ginkgo Bioworks, Zymergen, Synthace, Codexis, Twist Bioscience, Evonetix, Arzeda, Synthorx, Amyris, Novozymes, Desktop Genetics, Synlogic and Molecular Machines & Industries.
In November 2022, Novozymes, the world leader in biological solutions, and LinusBio (Linus Biotechnology Inc.), a leader in precision exposome sequencing, announced the companies are forming a collaboration to test a new, non-invasive technology in a clinical trial.
In October 2022, Ginkgo Bioworks and Zymergen announced that Ginkgo has completed its previously announced acquisition of Zymergen. The acquisition is expected to significantly enhance Ginkgo's platform by integrating strong automation and software capabilities as well as a wealth of experience across diverse biological engineering approaches.